LYSAKARE Trademark

Trademark Overview

On Wednesday, March 22, 2023, a trademark application was filed for LYSAKARE with the United States Patent and Trademark Office. The USPTO has given the LYSAKARE trademark a serial number of 79367737. The federal status of this trademark filing is REGISTERED as of Tuesday, May 28, 2024. This trademark is owned by ADVANCED ACCELERATOR APPLICATIONS INTERNATIONAL SA. The LYSAKARE trademark is filed in the Pharmaceutical Products category with the following description:

solution of amino acids intended to protect the kidney during therapeutic treatments by targeted internal radiotherapy of neuroendocrine tumors
lysakare

General Information

Serial Number79367737
Word MarkLYSAKARE
Filing DateWednesday, March 22, 2023
Status700 - REGISTERED
Status DateTuesday, May 28, 2024
Registration Number7394256
Registration DateTuesday, May 28, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements

Goods and Servicessolution of amino acids intended to protect the kidney during therapeutic treatments by targeted internal radiotherapy of neuroendocrine tumors
Pseudo MarkLISA CARE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 17, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameADVANCED ACCELERATOR APPLICATIONS INTERNATIONAL SA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameADVANCED ACCELERATOR APPLICATIONS INTERNATIONAL SA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameADVANCED ACCELERATOR APPLICATIONS INTERNATIONAL SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Friday, April 14, 2023SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Monday, April 17, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 21, 2023APPLICATION FILING RECEIPT MAILED
Monday, December 18, 2023ASSIGNED TO EXAMINER
Thursday, December 21, 2023NON-FINAL ACTION WRITTEN
Friday, December 22, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, January 2, 2024REFUSAL PROCESSED BY MPU
Tuesday, January 2, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, January 12, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 30, 2024REFUSAL PROCESSED BY IB
Wednesday, February 21, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 21, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 28, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 28, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, July 8, 2024NOTIFICATION PROCESSED BY IB
Wednesday, August 28, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, November 13, 2024GENERIC MADRID TRANSACTION CREATED
Thursday, November 14, 2024GENERIC MADRID TRANSACTION SENT TO IB
Saturday, December 21, 2024FINAL DECISION TRANSACTION PROCESSED BY IB

Related Keywords

lysakare targeted treatments internal radiotherapy tumors neuroendocrine therapeutic during acids amino